Rewalk Robotics Ltd
Prices are adjusted according to historical splits.
Vitals
- Today's Low:
- $0.7441
- Today's High:
- $0.83
- Open Price:
- $0.8
- 52W Low:
- $0.56
- 52W High:
- $1.01
- Prev. Close:
- $0.778
- Volume:
- 382938
Company Statistics
- Market Cap.:
- $46.63 million
- Book Value:
- 0.994
- Revenue TTM:
- $5.63 million
- Operating Margin TTM:
- -354.6%
- Gross Profit TTM:
- $1.91 million
- Profit Margin:
- 0%
- Return on Assets TTM:
- -16.47%
- Return on Equity TTM:
- -28.22%
Company Profile
Rewalk Robotics Ltd had its IPO on 2014-09-12 under the ticker symbol RWLK.
The company operates in the Healthcare sector and Medical Devices industry. Rewalk Robotics Ltd has a staff strength of 56 employees.
Stock update
Shares of Rewalk Robotics Ltd opened at $0.8 at the start of the last trading session i.e. 2023-09-12.
The stocks traded within a range of $0.74 - $0.83, and closed at $0.83.
This is a +6.68% increase from the previous day's closing price.
A total volume of 382,938 shares were traded at the close of the day’s session.
In the last one week, shares of Rewalk Robotics Ltd have increased by +16.57%.
Rewalk Robotics Ltd's Key Ratios
Rewalk Robotics Ltd has a market cap of $46.63 million, indicating a price to book ratio of 0.7069 and a price to sales ratio of 11.0194.
In the last 12-months Rewalk Robotics Ltd’s revenue was $5.63 million with a gross profit of $1.91 million and an EBITDA of $-19812000. The EBITDA ratio measures Rewalk Robotics Ltd's overall financial performance and is widely used to measure its profitability.
In the trailing 12-month period, Rewalk Robotics Ltd’s operating margin was -354.6% while its return on assets stood at -16.47% with a return of equity of -28.22%.
In Q2, Rewalk Robotics Ltd’s quarterly earnings growth was a positive 0% while revenue growth was a negative 14.8%.
Rewalk Robotics Ltd’s PE and PEG Ratio
- Forward PE
- 0
- Trailing PE
- 0
- PEG
- 0
Its diluted EPS in the last 12-months stands at $-0.37 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of 0. A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.
The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Rewalk Robotics Ltd’s profitability.
Rewalk Robotics Ltd stock is trading at a EV to sales ratio of 0.7161 and a EV to EBITDA ratio of 1.1245. Its price to sales ratio in the trailing 12-months stood at 11.0194.
Rewalk Robotics Ltd stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.
Balance sheet and cash flow metrics
- Total Assets
- $65.81 million
- Total Liabilities
- $5.44 million
- Operating Cash Flow
- $0
- Capital Expenditure
- $0
- Dividend Payout Ratio
- 0%
Rewalk Robotics Ltd ended 2024 with $65.81 million in total assets and $0 in total liabilities. Its intangible assets were valued at $65.81 million while shareholder equity stood at $58.97 million.
Rewalk Robotics Ltd ended 2024 with $0 in deferred long-term liabilities, $5.44 million in other current liabilities, 4435000.00 in common stock, $-222713000.00 in retained earnings and $0 in goodwill. Its cash balance stood at $58.18 million and cash and short-term investments were $58.18 million. The company’s total short-term debt was $616,000 while long-term debt stood at $0.
Rewalk Robotics Ltd’s total current assets stands at $63.84 million while long-term investments were $0 and short-term investments were $0. Its net receivables were $774000.00 compared to accounts payable of $2.85 million and inventory worth $3.04 million.
In 2024, Rewalk Robotics Ltd's operating cash flow was $0 while its capital expenditure stood at $0.
Comparatively, Rewalk Robotics Ltd paid $0 in dividends in 2024.
Other key metrics
- Current Trading Price
- $0.83
- 52-Week High
- $1.01
- 52-Week Low
- $0.56
- Analyst Target Price
- $3
Rewalk Robotics Ltd stock is currently trading at $0.83 per share. It touched a 52-week high of $1.01 and a 52-week low of $1.01. Analysts tracking the stock have a 12-month average target price of $3.
Its 50-day moving average was $0.71 and 200-day moving average was $0.72 The short ratio stood at 4.4 indicating a short percent outstanding of 0%.
Around 1759.4% of the company’s stock are held by insiders while 837.1% are held by institutions.
Frequently Asked Questions About Rewalk Robotics Ltd
Similar Industry Stocks (Medical Devices)
Most Active
Top Gainers
Top Losers
About
ReWalk Robotics Ltd., a medical device company, designs, develops, and commercializes robotic exoskeletons for individuals with mobility impairments or other medical conditions in the United States, Europe, the Asia-Pacific, and Africa. The company offers ReWalk Personal and ReWalk Rehabilitation for spinal cord injuries and everyday use by paraplegic individuals at home and in communities; ReStore, a soft exo-suit intended for use in the rehabilitation of individuals with lower limb disability due to stroke in the clinical rehabilitation environment; and MyoCycle and MediTouch tutor movement biofeedback devices for use at home or in clinic. It markets and sells its products directly to third party payers; institutions, including rehabilitation centers; and individuals, as well as through third-party distributors. The company was formerly known as Argo Medical Technologies Ltd. ReWalk Robotics Ltd. was incorporated in 2001 and is headquartered in Yokneam Ilit, Israel.